Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. - Wikidata - wikimedia - TriplyDB

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.

http://www.wikidata.org/entity/Q43369482

about

Adjuvant radiotherapy for stage I endometrial cancer Adjuvant radiotherapy for stage I endometrial cancer Pelvic radiotherapy and sexual function in women Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement Improving quality of life in female cancer survivors: current status and future questions.Fatigue related to radiotherapy for breast and/or gynaecological cancer: a systematic review.Clinical implementation of MR-guided vaginal cylinder brachytherapy.Concomitant endometrial and pancreatic cancers.Controversies in the management of endometrial carcinoma.Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study.A novel method for vaginal cylinder treatment planning: a seamless transition to 3D brachytherapy.Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review The diagnosis and treatment of endometrial cancer: progress and controversies.Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study.Controversies in the adjuvant therapy of endometrial cancer Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer.The role of radiotherapy in endometrial cancer: current evidence and trends Endometrial cancer - reduce to the minimum. A new paradigm for adjuvant treatments?Rectal bleeding after radiation therapy for endometrial cancer.Emotion episodes during psychotherapy sessions among women newly diagnosed with gynecological cancers.Controversies in the management of endometrial carcinoma: an update.Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.Treatment outcomes and prognostic factors in mexican patients with endometrial carcinoma with emphasis on patients receiving radiotherapy after surgery: an institutional perspective.Controversies in the treatment of early stage endometrial carcinoma.Contemporary quality of life issues affecting gynecologic cancer survivors.Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma.The effect of postoperative beam, implant, and combination radiation therapy on GI and bladder toxicities in female Medicare beneficiaries with stage I uterine cancer.Predictive and prognostic factors in definition of risk groups in endometrial carcinoma.Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecological cancers.A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.High-risk endometrial cancer may be benefit from adjuvant radiotherapy plus chemotherapy A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlle Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?Acute 'strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke.Assessment and significance of quality of life in women with gynecologic cancer.Evidence-based review of the utility of radiation therapy in the treatment of endometrial cancer.Current therapy of patients with endometrial carcinoma. A critical review.Patient-Reported Physical Function Measures in Cancer Clinical Trials.Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial.

P2860

Q24200253-A06F1A12-0B40-4172-B18E-2EEA922E0D6C Q24201209-A39FF28F-EF69-4E4F-AD08-5263E1899D5F Q26773698-B55F21F1-644C-4CD4-A117-522810867FD1 Q28069514-1B701B94-2198-475E-9E80-3AE7B23DD0BA Q30458386-1CD6F78F-DB9F-47BE-A1D2-D8B60358C0C5 Q30559074-E31DE40F-4379-4A92-94EA-0C4D3DD2AAD8 Q31033709-FCE41E54-DC70-4686-A038-096EDD097248 Q33763759-74958072-5FAA-4FFF-9B58-3C50AF30E615 Q33960894-FC0FE873-E554-4731-A50B-0EB6D3D245CC Q34231332-1A795DB1-C839-4B7B-892A-73B4818C631D Q34561938-FB946274-F679-43BD-BC70-4B901AA60810 Q34857343-BAAA26C5-AE5A-4FAB-AB9F-5A58984051BF Q35196619-706F168F-2C0F-45D6-9175-C62BD7765208 Q35208192-DA174D5C-BE77-4890-9B8F-DF74D3009422 Q35238303-FFAC4C21-FD78-45EE-A22A-85BAE82DDEBA Q35278722-58D90A7A-67FB-408E-90D2-623DBFB280C2 Q35539990-87CB7A4B-1744-4E03-8393-36E71B4B29D4 Q35617503-9193974E-D105-4BCC-87CB-36EFA49DB41E Q35744132-53053821-60AC-46ED-8153-9F7379DD5AE8 Q35752294-0E922A4C-C507-409D-8C98-BFE8DAF1357C Q35837883-542C9377-1126-4386-BAFA-CAB56532D9B4 Q35849504-5EA221E5-F938-41EE-895B-8E5CAD46450A Q35996813-B77E7581-B2B3-440D-88A2-C30C913866E4 Q36012083-BC01CBBF-1929-4A3C-A641-EAA194C92E64 Q36067725-BD7061A6-904C-467F-B265-CBB5CBEA1631 Q36313283-2D522C55-53D3-4F5B-AB48-C16654A92237 Q36372740-A472CFBF-CBFD-4D89-9DFE-DE02C95E0D8B Q36417927-C72BCF02-43D5-499E-A6B7-5CCC2C132ECD Q36501657-379AE8FA-C059-4DBE-824C-95143C14C017 Q36544016-418A97B4-9636-46D7-9BA5-0D0AAC7041CF Q36551196-9F860FCE-53CC-432C-A969-4EE03E5E8ED3 Q36621368-6963D14D-86E5-4017-A11A-9ADB474D8947 Q37139359-E06DE19A-51C1-4901-A566-C10780B551C2 Q37590689-4FE35898-701F-4C64-9A75-CAB4567326F9 Q37639321-74EA88F4-5206-4C18-898E-0662D0A19186 Q37783619-0D365BD0-0F3B-47FF-BC97-FAE12F9037E2 Q37795805-5CBDBC81-4245-4FF4-96D0-B2B502F6A234 Q37970571-7D587D10-5A87-453F-951C-6AFF8368584F Q39270037-88F394FE-5CB4-4C5D-853E-1605A3CEBDE2 Q39763096-37989B84-EDC3-419D-B982-F9A4C250F651

P2860

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.

http://www.wikidata.org/entity/Q43369482

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Quality of life after pelvic r ...... the randomized PORTEC-2 trial.

@en

Quality of life after pelvic r ...... the randomized PORTEC-2 trial.

@nl

type

label

Quality of life after pelvic r ...... the randomized PORTEC-2 trial.

@en

Quality of life after pelvic r ...... the randomized PORTEC-2 trial.

@nl

prefLabel

Quality of life after pelvic r ...... the randomized PORTEC-2 trial.

@en

Quality of life after pelvic r ...... the randomized PORTEC-2 trial.

@nl

P1433

Q43369482-0614284C-35FA-4A9F-8C29-06C16FFB291D

P1476

Q43369482-6A75ED07-C5F9-415C-A08B-9BF892FCB253

P2093

Q43369482-0DC4E8FC-680A-41C4-9815-053940E2B717

Q43369482-2321168F-4700-49D1-AAB8-00424DDE4133

Q43369482-36B99B12-B634-4F82-9099-38DF3DAC0DA2

Q43369482-54BE3344-32FD-4A95-97F4-338836692D4C

Q43369482-6D983A4B-893E-46DE-8FA7-BF65F6A84A60

Q43369482-6F32CFA0-6D5C-409B-BE4D-410B41B9510E

Q43369482-7D86FC2D-BAB7-455D-9358-924F2A351FA3

Q43369482-8B983881-F215-4B20-9377-A3893212927D

Q43369482-926354C6-B7F0-4853-B61F-B64BEC14A3A2

Q43369482-A1630CB7-7E89-4187-8BC9-42D85956FF6E

P304

Q43369482-83DAB134-C499-40E3-B30E-A9F3C3A5C148

P31

Q43369482-63CF68A7-FB71-4F34-9DF9-685953FABA4F

P356

Q43369482-B792AF32-F818-4635-A29F-EAF9C326FB53

P407

Q43369482-07F5EA36-1B8B-44A5-AB92-7DCB6E5C9E5F

P433

Q43369482-7CB0BDAE-E2BC-4EDC-B904-B5EFF124428E

P478

Q43369482-235C1F64-071F-4862-8538-028C55571FF9

P50

Q43369482-2C959D54-DFBC-49AA-8D88-49FC5C985222

P577

Q43369482-CEA45BA0-6AD8-48DE-B528-1FFA2BFE026F

P5875

Q43369482-BA86F891-76B5-4B70-ADC7-06756677DEE2

P698

Q43369482-3A3E54D7-DD17-4162-877C-8C5A7C888823

P921

Q43369482-0E49CE57-E43C-436B-B998-897E9FA957F9

Q43369482-72B1DFEE-17D0-445E-8B8A-618632FDFB48

Q43369482-803FB3B5-A5D1-44AA-90DA-AE3AE474F1BC

P356

JCO.2008.20.2424

P1433

Journal of Clinical Oncology

P1476

Quality of life after pelvic r ...... the randomized PORTEC-2 trial.

@en

P2093

Annerie Slot

http://www.w3.org/2001/XMLSchema#string

Bart N F M van Bunningen

http://www.w3.org/2001/XMLSchema#string

Elzbieta M van der Steen-Banasik

http://www.w3.org/2001/XMLSchema#string

Hans W Nijman

http://www.w3.org/2001/XMLSchema#string

Hein Putter

http://www.w3.org/2001/XMLSchema#string

Ina M Jürgenliemk-Schulz

http://www.w3.org/2001/XMLSchema#string

Jan J Jobsen

http://www.w3.org/2001/XMLSchema#string

Jan Willem M Mens

http://www.w3.org/2001/XMLSchema#string

Ludy C H W Lutgens

http://www.w3.org/2001/XMLSchema#string

Marika C Stenfert Kroese

http://www.w3.org/2001/XMLSchema#string

P304

3547-3556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.20.2424

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Carien L Creutzberg

P577

2009-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26310968

http://www.w3.org/2001/XMLSchema#string

P698

19546404

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

radiation therapy